Are Women’s Breast Cancer Risk Appraisals in Line with Updated Clinical Risk Estimates Communicated? Results from a UK Family History Risk and Prevention Clinic
Further research is warranted to assess whether similar patterns emerge for other illnesses and in different clinical contexts to determine the best strategies for communicating updated risk estimates.
Authors
- Lynne Fox (ORCID: https://orcid.org/0000-0003-3891-3190)
- Lorna McWilliams (ORCID: https://orcid.org/0000-0002-6414-2732)
- David French (ORCID: https://orcid.org/0000-0002-7663-7804)
- Anthony Howell (ORCID: https://orcid.org/0000-0002-6233-719X)
- Victoria G. Woof (ORCID: https://orcid.org/0000-0003-4069-5188)
- D. Gareth Evans (ORCID: https://orcid.org/0000-0002-8482-5784)
Institutions
- Florence Nightingale Foundation (GB)
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-0581
- Citations
- 4
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.65
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- Manchester Biomedical Research Centre
- Medical Research Council